Prescription drug · NDA
Neurolite (Bicisate dihydrochloride) NDC 87333-006
Kit · SHINE SPECT USA, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 87333-006-02 | 87333000602 | 2 KIT in 1 PACKAGE, COMBINATION (87333-006-02) / 1 KIT in 1 KIT * 1 INJECTION in 1 VIAL (87333-002-01) * 1 mL in 1 VIAL (87333-004-01)Marketed from Sep 10, 2026 | |
| 87333-006-05 | 87333000605 | 5 KIT in 1 PACKAGE, COMBINATION (87333-006-05) / 1 KIT in 1 KIT * 1 INJECTION in 1 VIAL (87333-002-01) * 1 mL in 1 VIAL (87333-004-01)Marketed from Sep 10, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Neurolite
- Generic name (nonproprietary)
- bicisate dihydrochloride
- Dosage form
- Kit
- Labeler
- SHINE SPECT USA, LLCNDC labeler code 87333
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020256
- Marketing start
- Listing expires
- Identifiers
- Product ID 87333-006_723b95b6-fc1e-4f5f-9102-5fcaa4ea4400SPL ID 723b95b6-fc1e-4f5f-9102-5fcaa4ea4400SPL set ID e2c9efae-4e57-4f05-ac72-5443dea03f38
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N487333000602followed by a unit qualifier and the quantityPackage 87333-0006-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS NEUROLITE ® single photon emission computerized tomography (SPECT) is indicated as an adjunct to conventional CT or MRI imaging in the localization of stroke in patients in whom stroke has already been diagnosed. NEUROLITE ® is not indicated for assessment of functional viability of brain tissue. Also, NEUROLITE ® is not indicated for distinguishing between stroke and other brain lesions.
Excerpt only. Read the full label for complete information.
About NDC 87333-006
- What is NDC 87333-006?
- 87333-006 is the product NDC for Neurolite (bicisate dihydrochloride) kit, listed with the FDA by SHINE SPECT USA, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Neurolite (Bicisate dihydrochloride).
- Who is the labeler?
- SHINE SPECT USA, LLC, NDC labeler code 87333. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Neurolite?
- 1 other product NDC are listed under this name. See all Neurolite NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Neurolite products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Neurolitebicisate dihydrochloride | — | Kit | Lantheus Medical Imaging, Inc. | 11994-006 | 11994-0006-0211994-0006-05 |
Other NDCs under NDA 020256
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Neurolitebicisate dihydrochloride | — | Kit | Lantheus Medical Imaging, Inc. | 11994-006 |